Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide

Journal of Neuro-Oncology

Volumn 114, Issue 1, 2013, Pages 111-116

  Reddy, Krishna ^a   Gaspar, Laurie E ^a   Kavanagh, Brian D ^a   Waziri, Allen ^a   Damek, Denise M ^a   Ney, Douglas ^a   Lillehei, Kevin O ^a   Chen, Changhu ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Glioblastoma; High grade glioma; Hypofractionation; Quality of life

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PAIN; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COGNITION; COMMUNICATION DISORDER; DROWSINESS; EMOTIONAL FUNCTIONING; FATIGUE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEADACHE; HEALTH STATUS; HUMAN; INSOMNIA; INTENSITY MODULATED RADIATION THERAPY; MALE; MOTOR DYSFUNCTION; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PHYSICAL FUNCTIONING; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION NECROSIS; ROLE FUNCTIONING; SEIZURE; SOCIAL INTERACTION; SURVIVAL TIME; VISUAL DISORDER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COGNITION; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84881156635     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1159-6     Document Type: Article

References (12)

1. Giovagnoli AR, Silvani A, Colombo E et al (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562-568
2. Li J, Bentzen SM, Renschler M et al (2008) Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71:64-70
3. Jakola AS, Gulati S, Weber C et al (2011) Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study. PLoS ONE 6(12):e28592
4. Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 104:639-646
5. Reddy K, Damek D, Gaspar LE et al (2012) Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84(3):655-660
6. Fayers P, Bottomley A (2002) Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38(4):S125-S133
7. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
8. Osoba D, Aaronson NK, Muller M et al (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139-150
9. Fayers P, Aaronson N, Bjordal K et al (2001) EORTC QLQ-C30 scoring manual, 3rd edn. EORTC, Brussels
10. Taphoorn MJ, Stupp R, Coens C et al (2005) Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937-944
11. Corn BW, Wang M, Fox S et al (2009) Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. J Neurooncol 95:247-257
12. Walker M, Brown J, Brown K et al (2003) Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol 63:179-186